tiprankstipranks
Trending News
More News >
Arcus Biosciences Inc (RCUS)
NYSE:RCUS
US Market

Arcus Biosciences (RCUS) Income Statement

Compare
534 Followers

Arcus Biosciences Income Statement

Last quarter (Q3 2025), Arcus Biosciences's total revenue was $26.00M, a decrease of -45.83% from the same quarter last year. In Q3, Arcus Biosciences's net income was $-135.00M. See Arcus Biosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 258.00M$ 117.00M$ 112.00M$ 383.00M$ 78.00M
Gross Profit
$ 258.00M$ 117.00M$ 112.00M$ 383.00M$ 78.00M
Operating Expenses
$ 588.00M$ 457.00M$ 392.00M$ 329.00M$ 202.00M
Depreciation and Amortization
$ 10.00M$ 8.00M$ 6.00M$ 4.00M$ 3.00M
EBITDA
$ -269.00M$ -291.00M$ -258.00M$ 59.00M$ -120.00M
Operating Income
$ -330.00M$ -340.00M$ -280.00M$ 54.00M$ -124.00M
Other Income/Expenses
$ 47.00M$ 39.00M$ 14.00M$ 1.00M$ 1.00M
Pretax Income
$ -283.00M$ -301.00M$ -266.00M$ 55.00M$ -123.00M
Net Income
$ -283.00M$ -307.00M$ -267.00M$ 53.00M$ -123.00M
Per Share Metrics
Basic EPS
$ -3.14$ -4.15$ -3.71$ 0.76$ -2.13
Diluted EPS
$ -3.14$ -4.15$ -3.71$ 0.71$ -2.13
Weighted Average Shares Outstanding
90.10M 74.00M 72.00M 69.35M 54.79M
Weighted Average Shares Outstanding (Diluted)
90.10M 74.00M 72.00M 73.97M 54.79M
Currency in USD

Arcus Biosciences Earnings and Revenue History